Healthy adults under 30 should be offered an alternative vaccine to the Oxford/AstraZeneca jab if there is one available in their area and they are not at high risk of Covid, following concerns over rare blood clots, the UK government’s vaccination advisory body has said. England’s deputy chief medical officer, Prof Jonathan Van-Tam, said the vaccine’s risk versus benefit ratio was ‘finely balanced’ for younger people
This content first appear on the guardian